Medications

Developing the first drug for a deadly bone disease

The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...

Biomedical technology

Wearable, 3D printed tech could become physiotherapy tool

Stretchy and with built-in sensing capability, interactive surfaces that act like fabric are being developed by Te Whare Wānanga o Waitaha | University of Canterbury (UC) Computer Science and Software Engineering Lecturer ...

page 8 from 40